In a nutshell This study investigated blood glucose control in the second and third trimesters and pregnancy outcomes in women with type 1 diabetes. The authors concluded that regular testing of average blood glucose levels could be beneficial, as higher levels were associated with adverse outcomes. Some background Patients with type 1 diabetes...
Read More
In a nutshell This study assessed whether physical activity during pregnancy could help control blood sugar levels in women diagnosed with pregnancy-related diabetes. The authors concluded that taking part in both moderate- and vigorous-intensity activity helped keep blood sugar levels within recommended ranges. Some background Gestational...
Read More
In a nutshell This study investigated whether or not it was safe for pregnant women with diabetes to express breast-milk before birth. The authors concluded that expressing milk from 36 weeks of pregnancy was safe in patients at low risk of complications. Some background Babies born to women with diabetes are at an increased risk of hypoglycemia...
Read More
In a nutshell This study determined whether the levels of a particular protein, FABP4 predicted pre-eclampsia in pregnant women with type 1 diabetes. The authors concluded that the addition of blood FABP4 measurements improved overall accuracy in assessing the risk of pre-eclampsia. Some background Pre-eclampsia is a condition that can develop...
Read More
In a nutshell This study determined the suitability of adding empagliflozin (Jardiance) to the combination of metformin (Glucophage) and linaglipton (Tradjenta) in type 2 diabetes. The authors concluded that adding empagliflozin was effective in patients whose blood sugar was not controlled by the combination of metformin and linaglipton alone. Some...
Read More
In a nutshell This study explored whether glucagon-like peptide-1 receptor agonists (GLP-1RAs) were effective in treating type-2 diabetes. The authors concluded that all GLP-1RA’s were effective and that the type of GLP-1RA chosen could be tailored to a patient’s specific needs. Some background Insulin is a hormone which controls...
Read MoreIn a nutshell This study investigated the prevalence of hypoglycemia (dangerously low blood glucose) and awareness of hypoglycemia in adults with type 1 diabetes (T1D). The study concluded that at least 1 in 5 adults with T1D had experienced severe hypoglycemia in the last 6 months, and/or had impaired awareness of hypoglycemia (IAH). Some background...
Read MoreIn a nutshell This study investigated whether interrupting sitting with light-intensity walking could improve glucose levels and insulin resistance in people with type 2 diabetes (T2D) more than structured exercise. It determined that while both routines reduced glucose levels, only interrupting sitting reduced insulin resistance. Some background...
Read More
In a nutshell This study investigated whether semaglutide could improve the function of beta cells and glycemic control in patients with type 2 diabetes. The study concluded that once-weekly treatment with semaglutide improved beta cell function and glycemic control in these patients. Some background Beta cells are located in the pancreas and are...
Read MoreIn a nutshell This study will investigate the ability of 3 different methods to improve self-care in patients with uncontrolled diabetes. These 3 methods are; text-messaging, health coaches, and enhanced usual care. This study will take place in Mississippi and Tennessee. The details Previous research suggests that encouraging text messages from...
Read More
In a nutshell This study compared the use of aflibercept (Eylea) with laser therapy for the treatment of proliferative diabetic retinopathy (PDR). This study determined that aflibercept may be a suitable alternative to laser therapy. Some background PDR is the most common cause of severe visual loss in people with diabetes. In...
Read MoreIn a nutshell This study looked at the safety and efficacy of long-acting insulin drug, Gla-300 in maintaining glycemic (blood sugar) control in adults with type 1 diabetes. This study concluded that patients taking Gla-300 had better glycemic control than those using Gla-100, a lower dose of the same basal insulin glargine. Some background...
Read More
